Luciano Silvestri
Research Subjects
Luciano Silvestri has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Hendrick K. F. van Saene
University of Liverpool
11 shared publications- Dario Gregori
Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35121 Padua, Italy
8 shared publications Durk F. Zandstra
University of Amsterdam, Amsterdam, The Netherlands
6 shared publicationsH. K. F. van Saene
Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom
6 shared publicationsHendrick K.F. van Saene
Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK
5 shared publicationsHendrick Kf van Saene
Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, L69 3GA, UK
5 shared publications
Latest Publications
- 1 December 2017
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 31 (6) , 2236-2244
Impact of Oral Chlorhexidine on Bloodstream Infection in Critically Ill Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 1 December 2017
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 31 (6) , 2236-2244
Impact of Oral Chlorhexidine on Bloodstream Infection in Critically Ill Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 1 November 2017
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 83 (11) , 1214-1215
Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy
Article: Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy - Minerva Anestesiologica 2017 November;83(11):1214-5 - Minerva Medica - Journals
- 1 November 2017
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 83 (11) , 1214-1215
Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy
Article: Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy - Minerva Anestesiologica 2017 November;83(11):1214-5 - Minerva Medica - Journals
- 1 July 2017
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 83 (7) , 776-777
Data crunching and p cracking can be misleading
Article: Data crunching and p cracking can be misleading - Minerva Anestesiologica 2017 July;83(7):776-7 - Minerva Medica - Journals
- 1 July 2017
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 83 (7) , 776-777
Data crunching and p cracking can be misleading
Article: Data crunching and p cracking can be misleading - Minerva Anestesiologica 2017 July;83(7):776-7 - Minerva Medica - Journals
- 27 December 2016
- Published by Springer Nature
- p. 79-86
Selective Decontamination of the Digestive Tract
- 27 December 2016
- Published by Springer Nature
- p. 79-86
Selective Decontamination of the Digestive Tract
- 1 August 2015
- Published by Elsevier in The Lancet
- Vol. 386 (9994) , 653
Parenteral antibiotics are not enough to prevent pneumonia in stroke
- 1 August 2015
- Published by Elsevier in The Lancet
- Vol. 386 (9994) , 653
Parenteral antibiotics are not enough to prevent pneumonia in stroke
- 31 March 2015
- Published by Springer Nature in Intensive Care Medicine
- Vol. 41 (5) , 954-956
Ventilator-associated pneumonia prevention: the issue is the control of oropharyngeal and gut overgrowth
- 31 March 2015
- Published by Springer Nature in Intensive Care Medicine
- Vol. 41 (5) , 954-956
Ventilator-associated pneumonia prevention: the issue is the control of oropharyngeal and gut overgrowth
- Open Access
- 1 January 2015
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 142 (1) , 90-1
Selective digestive decontamination saves lives whilst preventing resistance
- 1 January 2015
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 142 (1) , 90-1
Open AccessSelective digestive decontamination saves lives whilst preventing resistance
- 1 July 2014
- Vol. 80 (7) , 805-820
Effectiveness of oral chlorhexidine on nosocomial pneumonia, causative micro-organisms and mortality in critically ill patients: a systematic review and meta-analysis
We carried out a systematic review and meta-analysis of randomized trials to explore the effectiveness of oral chlorhexidine on nosocomial pneumonia, causative bacteria, and mortality PubMed, Embase, and the Cochrane Register of Controlled Trials were searched for randomized trials in critically ill patients receiving oral chlorhexidine. Odds ratios (OR) were pooled with the random effects model. Twenty-two randomized trials including 4277 patients were identified. Chlorhexidine significantly reduced the incidence of nosocomial pneumonia (OR 0.66; 95% confidence interval [CI] 0.51-0.85) and ventilator-associated pneumonia (OR 0.68, 95% CI 0.53-0.87). There was a significant reduction of nosocomial pneumonia due to both Gram-positive (OR 0.41; 95% CI 0.19-0.85) and Gram-negative (OR 0.68; 95% CI 0.51-0.90) bacteria, but only pneumonia due to "normal" flora (OR 0.51; 95% CI 0.33-0.80). The subgroup analysis revealed a significant benefit of chlorhexidine on nosocomial pneumonia in surgical patients only (OR 0.52; 95% CI 0.33-0.82). Mortality was not affected. This review indicates that in critically ill, mainly surgical, patients, oral chlorhexidine reduces nosocomial pneumonia, ventilator-associated pneumonia, nosocomial pneumonia due to Gram-positive and Gram-negative bacteria, and due to "normal" flora, without affecting mortality. Further studies should explore the efficacy of oral chlorhexidine in non-surgical critically ill population.
- 1 July 2014
- Vol. 80 (7) , 805-820
Effectiveness of oral chlorhexidine on nosocomial pneumonia, causative micro-organisms and mortality in critically ill patients: a systematic review and meta-analysis
We carried out a systematic review and meta-analysis of randomized trials to explore the effectiveness of oral chlorhexidine on nosocomial pneumonia, causative bacteria, and mortality PubMed, Embase, and the Cochrane Register of Controlled Trials were searched for randomized trials in critically ill patients receiving oral chlorhexidine. Odds ratios (OR) were pooled with the random effects model. Twenty-two randomized trials including 4277 patients were identified. Chlorhexidine significantly reduced the incidence of nosocomial pneumonia (OR 0.66; 95% confidence interval [CI] 0.51-0.85) and ventilator-associated pneumonia (OR 0.68, 95% CI 0.53-0.87). There was a significant reduction of nosocomial pneumonia due to both Gram-positive (OR 0.41; 95% CI 0.19-0.85) and Gram-negative (OR 0.68; 95% CI 0.51-0.90) bacteria, but only pneumonia due to "normal" flora (OR 0.51; 95% CI 0.33-0.80). The subgroup analysis revealed a significant benefit of chlorhexidine on nosocomial pneumonia in surgical patients only (OR 0.52; 95% CI 0.33-0.82). Mortality was not affected. This review indicates that in critically ill, mainly surgical, patients, oral chlorhexidine reduces nosocomial pneumonia, ventilator-associated pneumonia, nosocomial pneumonia due to Gram-positive and Gram-negative bacteria, and due to "normal" flora, without affecting mortality. Further studies should explore the efficacy of oral chlorhexidine in non-surgical critically ill population.
- Open Access
- 27 May 2014
- Published by Springer Nature in Intensive Care Medicine
- Vol. 40 (7) , 1065
Colistin, SDD and resistance: nihil novi sub sole
- 27 May 2014
- Published by Springer Nature in Intensive Care Medicine
- Vol. 40 (7) , 1065
Open AccessColistin, SDD and resistance: nihil novi sub sole